Utility of a Recombinant HSV-1 Vaccine Vector for Personalized Cancer Vaccines

Current approaches to cancer immunotherapy include immune checkpoint inhibitors, cancer vaccines, and adoptive cellular therapy. These therapies have produced significant clinical success for specific cancers, but their efficacy has been limited. Oncolytic virotherapy (OVT) has emerged as a promisin...

Descripción completa

Detalles Bibliográficos
Autores principales: Uche, Ifeanyi Kingsley, Stanfield, Brent A., Rudd, Jared S., Kousoulas, Konstantin G., Rider, Paul J. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826227/
https://www.ncbi.nlm.nih.gov/pubmed/35155582
http://dx.doi.org/10.3389/fmolb.2022.832393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826227/
https://www.ncbi.nlm.nih.gov/pubmed/35155582
http://dx.doi.org/10.3389/fmolb.2022.832393

Ejemplares similares